The Mycobacterium tuberculosis Type VII secretion system ESX-5, which has been implicated 16 in virulence, is activated at the transcriptional level by the phosphate starvation responsive 17 Pst/SenX3-RegX3 signal transduction system. Deletion of pstA1, which encodes a Pst 18 phosphate transporter component, causes constitutive activation of the response regulator 19 RegX3, hyper-secretion of ESX-5 substrates and attenuation in the mouse infection model. We 20 hypothesized that constitutive activation of ESX-5 secretion causes attenuation of the ∆pstA1 21 mutant. To test this, we uncoupled ESX-5 from regulation by RegX3. Using electrophoretic 22 mobility shift assays, we defined a RegX3 binding site in the esx-5 locus. Deletion or mutation of 23 the RegX3 binding site reversed hyper-secretion of the ESX-5 substrate EsxN by the ∆pstA1 24 mutant and abrogated induction of EsxN secretion in response to phosphate limitation by wild-25 type M. tuberculosis. Deletion of the esx-5 RegX3 binding site (∆BS) suppressed attenuation of 26 the ∆pstA1 mutant in Irgm1 -/mice, suggesting that constitutive ESX-5 secretion limits M.
to RegX3 when added in excess. The mutated DR3 competitor reversed the mobility shift, 145 indicating RegX3 can still bind this sequence (Fig. 1E ). However, the mutated DR1 or DR2 146 competitors both failed to reverse the mobility shift, indicating that RegX3 cannot bind these 147 mutated sequences (Fig. 1E) . These data indicate that the DR1 and DR2 sequence elements 148 are required for RegX3 binding in vitro. Altering the spacing between DR1 and DR2, either by 149 adding or removing 3 bp, abrogates RegX3 binding, since the Spc+3 and Spc-3 competitors 150 also failed to reverse the mobility shift (Fig. 1E ). This indicates that RegX3 requires a 5 bp 151 spacer between DR1 and DR2 for in vitro binding. The 27 bp RegX3 binding site sequence, 152 including DR1 and DR2, located approximately 100 bp upstream of the pe19 start codon is 153 consistent with RegX3 functioning as a transcriptional activator of esx-5 genes (14).
154
RegX3 binding site mutations in the ∆pstA1 mutant reverse esx-5 over-expression and 155 hyper-secretion of EsxN. We previously demonstrated that esx-5 transcripts are over-156 expressed during growth in P i -replete conditions in the ∆pstA1 mutant due to constitutive 157 activation of RegX3 (14) . To determine if esx-5 over-expression also depends upon the esx-5 158 RegX3 binding site that we defined, we introduced three distinct RegX3 binding site mutations 159 at the intergenic region 5' of pe19 on the chromosome of the M. tuberculosis ∆pstA1 mutant.
160
The DR2 direct repeat mutant (∆pstA1 DR2 ) harbors the transversion mutations in DR2 identical 161 those tested for RegX3 binding in vitro (Fig. 1C ). The spacer mutant (∆pstA1 Spc+3 ) harbors three 162 additional bp between DR1 and DR2, identical to the Spc+3 mutation tested for RegX3 binding 163 in vitro (Fig. 1C) . Finally, the binding site deletion mutant (∆pstA1∆BS) harbors a deletion of the 164 complete 27 bp RegX3 binding site located at -128 to -102 bp relative to the pe19 start codon.
165
We tested expression of esx-5 genes in the ∆pstA1 DR2 , ∆pstA1 Spc+3 and ∆pstA1∆BS binding site 166 mutants grown in standard P i -rich medium ( Fig. 2A) . The ∆pstA1 mutant exhibited significant 167 over-expression of the pe19 and espG 5 transcripts (P<0.0001) and more than 3-fold over-168 expression of eccD 5 as compared to the WT control ( Fig. 2A) . As previously reported, over-169 expression of these transcripts was dependent on RegX3 since expression of each gene was 170 restored to the WT level in the ∆pstA1∆regX3 mutant ( Fig. 2A) (14) . In both the ∆pstA1 DR2 and 171 ∆pstA1∆BS mutants, transcription of pe19, espG 5 , and eccD 5 was similarly restored to levels 172 that were nearly the same as and not significantly different from the WT control ( Fig. 2A) . Both 173 the ∆pstA1 DR2 and ∆pstA1∆BS mutants also exhibited statistically significant reductions in pe19 174 and espG 5 transcription relative to the ∆pstA1 parental control ( Fig. 2A) . The pe19, espG 5 , and 175 eccD 5 transcripts were detected at intermediate levels in the ∆pstA1 Spc+3 mutant that were not 176 significantly reduced as compared to the ∆pstA1 parental strain ( Fig. 2A) . These data 177 demonstrate that the RegX3 binding site within the esx-5 locus, and the DR2 sequence in 178 particular, is required for RegX3-mediated over-expression of esx-5 genes in the ∆pstA1 179 mutant.
180
RegX3 is a global response regulator that activates and represses many genes outside 181 of the esx-5 locus (24). To determine if the RegX3 binding site mutations that we introduced 182 perturbed regulation exclusively at the esx-5 locus, we examined transcription of other genes 183 that are over-expressed by the ∆pstA1 mutant in a RegX3-dependent manner, but that are not 184 associated with esx-5 (24). The udgA and mgtA transcripts were over-expressed by the ∆pstA1 185 mutant relative to both the WT and ∆pstA1∆regX3 strains (Fig. S1 ). Both udgA and mgtA 186 transcripts remained significantly over-expressed in the ∆pstA1 DR2 , ∆pstA1 Spc+3 and ∆pstA1∆BS 187 mutants ( Fig. S1 ). These data demonstrate that mutation of the RegX3 binding site sequence 188 within the esx-5 locus does not globally alter RegX3 activity.
189
To determine if the decreased transcription of esx-5 genes in the RegX3 binding site 190 mutants translates to changes in stability or activity of the ESX-5 secretion system, we 191 monitored production of ESX-5 conserved components and secretion of the ESX-5 substrates 192 EsxN and PPE41 by the ∆pstA1 RegX3 binding site mutants. We observed hyper-secretion of 193 the ESX-5 substrates EsxN and PPE41 and over-production of the cytosolic ESX-5 chaperone
194
EspG 5 and ESX-5 secretion machinery components EccB 5 and EccD 5 by the ∆pstA1 mutant 195 relative to the WT control ( Fig. 2B ). This response required RegX3 (Fig. 2B ), consistent with our 196 prior report (14) . We detected reduced amounts of the EspG 5 , EccB 5 and EccD 5 proteins in all 197 three ∆pstA1 RegX3 binding site mutants as compared to the ∆pstA1 mutant ( Fig. 2B ). EsxN 198 hyper-secretion was reversed in both the ∆pstA1 DR2 and ∆pstA1∆BS mutants, reaching levels 199 that were undetectable, comparable to both the WT and ∆pstA1∆regX3 mutant controls (Fig. 
200
2B). We detected EsxN secretion by the ∆pstA1 Spc+3 mutant but at a 6-fold reduced abundance 201 as compared to the ∆pstA1 mutant ( Fig. 2B ). Secretion of PPE41 was also decreased in each of 202 the RegX3 binding site mutants relative to the ∆pstA1 parental strain, but remained 203 approximately 2-fold increased as compared to the WT control ( Fig. 2B ). It is possible either that 204 RegX3 controls PPE41 secretion by a mechanism independent of its regulation of esx-5 205 transcription, or that decreased secretion of EsxN frees the ESX-5 secretion apparatus to 206 translocate other substrates including PPE41. The ModD control confirmed equivalent loading 207 of the culture filtrate fraction; the GroEL2 control confirmed equivalent loading of the cell lysate 208 fraction and demonstrated that cell lysis did not contaminate the culture filtrate ( Fig. 2B ). These 209 results indicate that the RegX3 binding site in the esx-5 locus is required for the over-production 210 of ESX-5 secretion system core components and hyper-secretion of EsxN by the ∆pstA1 211 mutant.
212
Mutation of the RegX3 binding site in the esx-5 locus prevents ESX-5 induction during 213 phosphate limitation. We previously demonstrated that P i limitation triggers ESX-5 activity in 214 WT M. tuberculosis, and that this response requires RegX3 (14) . To determine if the RegX3 215 binding site is also required for induction of esx-5 transcription in response to P i limitation, we 216 generated a strain lacking the RegX3 binding site in the WT Erdman strain background (∆BS) 217 and conducted qRT-PCR experiments to monitor esx-5 gene expression. The WT, ∆regX3 and 218 ∆BS strains were grown in either P i -free medium or P i -replete medium as a control. In P i -replete 219 conditions, esx-5 transcripts were expressed at a basal level in all of the strains (Fig. 3B ).
220
Statistically significant increases in pe19 and espG 5 transcription were detected for the ∆BS 221 mutant, but the changes were less than 1.5-fold (Fig. 3B ). The pe19, espG 5 and eccD 5 222 transcripts were induced 7.9, 4.9, and 3.7-fold, respectively, by WT M. tuberculosis during 223 growth in P i -free medium relative to the P i -replete control (Fig. 3A) . The ∆regX3 mutant failed to 224 induce pe19, espG 5 or eccD 5 transcription in response to P i limitation, consistent with our 225 previous reports ( Fig. 3A) (14, 36) . The ∆BS mutant similarly failed to induce pe19, espG 5 or 226 eccD 5 transcription in response to P i limitation (Fig. 3A) ; the level of each transcript was 227 significantly different from that of the WT control and not significantly different from that of the 228 ∆regX3 mutant (Fig. 3A) . These data demonstrate that the RegX3 binding site in the esx-5 locus 229 is required for activation of esx-5 transcription in response to P i limitation.
230
We evaluated production of ESX-5 conserved components and secretion of the ESX-5 231 substrates EsxN and PPE41 during P i limitation in the ∆BS mutant by Western blotting.
232
Production of EspG 5 , EccB 5 and EccD 5 was induced in WT M. tuberculosis during P i limitation 233 ( Fig. 3C ), as previously demonstrated (14). Increased production or stability of EspG 5 , EccB 5 234 and EccD 5 during P i limitation was abrogated in both the ∆regX3 and ∆BS mutants ( Fig. 3C ).
235
The GroEL2 control confirmed equivalent loading of cell lysate proteins ( Fig. 3C ). Secretion of 236 EsxN and PPE41 was induced in the WT strain during P i limitation, as previously reported (14) 237 ( Fig. 3C ). Induction of EsxN secretion during P i limitation was prevented by either the ∆regX3 or 238 the ∆BS mutation ( Fig. 3C ). The ∆regX3 mutant also exhibited modestly reduced PPE41 239 secretion during P i limitation, as previously reported (14) ( Fig. 3C ). In contrast, the ∆BS mutant 240 induced PPE41 secretion during P i limitation similarly to the WT control ( Fig. 3C ), consistent 241 with our results demonstrating intermediate PPE41 secretion by the ∆pstA1∆BS mutant. The
242
ModD control confirmed equivalent loading of the P i -limited culture filtrate fraction (Fig. 3C) ; the 243 decreased secretion of ModD during P i limitation relative to the P i -replete control ( Fig. 3C ) was 244 consistent with our previous report (14). The GroEL2 control confirmed that cell lysis did not 245 contaminate the culture filtrate ( Fig. 3C ). Collectively, these data suggest that the RegX3 246 binding site within the esx-5 locus is necessary for induction of EsxN secretion during P i 247 limitation.
248
The esx-5 RegX3 binding site deletion suppresses attenuation of the ∆pstA1 mutant in 249 Irgm1 -/mice.
250
To determine if constitutive hyper-secretion of ESX-5 substrates contributes to attenuation 251 of the ∆pstA1 mutant we infected C57BL/6, NOS2 -/and Irgm1 -/mice via the aerosol route with 252 ~100 CFU of WT, ∆pstA1, or ∆pstA1∆BS M. tuberculosis strains. All Irgm1 -/mice succumbed to 253 infection with WT Erdman by 4 weeks post-infection, and bacterial loads reached over 10 9 in the 254 lungs ( Fig. 4A ). Irgm1 -/mice controlled replication of the ∆pstA1 mutant after 2 weeks post 255 infection ( Fig. 4A ), consistent with previous results (24). In contrast, the ∆pstA1∆BS mutant 256 replicated progressively in the lungs of Irgm1 -/mice. At 4 weeks post-infection, mean bacterial 257 CFU in the lungs of Irgm1 -/mice infected with the ∆pstA1∆BS mutant were increased 40-fold as 258 compared to mice infected with the ∆pstA1 mutant, though this difference did not achieve 259 statistical significance ( Fig. 4A ). However, by 6 weeks post-infection, the ∆pstA1∆BS mutant 260 reached nearly the same final bacterial burden in the lungs of Irgm1 -/mice as the WT control 261 ( Fig. 4A ). At 6 weeks, the bacterial burden of the ∆pstA1∆BS mutant in the lungs was over 262 1000-fold higher than the ∆pstA1 mutant, and this difference was statistically significant (Fig. 
263
4A). In these experiments, several of the Irgm1 -/mice infected with the ∆pstA1∆BS mutant were 264 moribund at the 6 week time point, while our previous experiments demonstrated that Irgm1 -/-265 mice infected with the ∆pstA1 mutant all survive for at least 14 weeks (24). These data suggest 266 that attenuation of the ∆pstA1 mutant in Irgm1 -/mice is due, at least in part, to constitutive 267 activity of the ESX-5 secretion system and increased secretion of one or more ESX-5 268 substrates. These data further suggest that hyper-secretion of ESX-5 substrates sensitizes M. 269 tuberculosis to a host immune response that is independent of Irgm1.
270
To determine if the modest attenuation of the ∆pstA1∆BS mutant relative to the WT 271 control might be due to the ∆BS mutation, we performed similar aerosol infection experiments 272 with the ∆BS mutant. The ∆BS mutant exhibited a modest but statistically significant decrease in 273 lung bacterial burden at the 4 week time point compared to the WT control, but all mice were 274 moribund by the 5 week time point and were euthanized (Fig. 4A ). These data suggest that the 275 partially attenuated phenotype of the ∆pstA1∆BS mutant in Irgm1 -/mice may be due to an 276 inability to induce ESX-5 secretion in response to P i limitation.
277
In NOS2 -/mice, in contrast, the ∆BS mutation had no statistically significant effect on the 278 ability of either the ∆pstA1 mutant or WT bacteria to replicate in the lungs (Fig. 4B ). These data 279 suggest that other factors besides increased ESX-5 secretion contribute to the attenuation of 280 the ∆pstA1 mutant in NOS2 -/mice.
281
Similarly, in C57BL/6 mice, deletion of the esx-5 RegX3 binding site sequence failed to 282 suppress the attenuated phenotype of the ∆pstA1 mutant during the chronic phase of infection 283 ( Fig. 4C ). There were no statistically significant differences in lung bacterial burden between the 284 ∆pstA1 and ∆pstA1∆BS mutants at any time point ( Fig. 4C ). In addition, at each time point the 285 CFUs in the lungs of C57BL/6 mice infected with either the ∆pstA1 mutant or the ∆pstA1∆BS 286 mutant were significantly different from the WT control ( Fig. 4C ). To determine if the ∆BS 287 mutation causes attenuation, we infected C57BL/6 mice by the aerosol route with the ∆BS 288 mutant. We observed modest but statistically significant decreases in lung bacterial burden at 289 the 2 week and 4 week time points in ∆BS-infected mice relative to mice infected with the WT 290 control ( Fig. 4C ). However, by 12 weeks post-infection, CFU in the lungs of both WT-and ∆BS-291 infected mice were similar ( Fig. 4C ). Taken together, these data suggest that other factors 292 besides increased ESX-5 secretion contribute to attenuation of the ∆pstA1 mutant during the 293 chronic phase of infection in C57BL/6 mice and that regulation of ESX-5 secretion in response 294 to P i limitation enhances acute phase replication of M. tuberculosis in the lungs.
295
EsxN hyper-secretion does not cause attenuation of the ∆pstA1 mutant.
296
To investigate whether attenuation of the ∆pstA1 mutant is due to inappropriate hyper-297 secretion of the ESX-5 substrate EsxN specifically, we deleted esxN in both WT and ∆pstA1 298 mutant backgrounds. The ∆esxN deletion was verified by PCR (data not shown) and qRT-PCR; 299 the esxN transcript was not detected in either ∆esxN mutant ( Fig. 5A ). Deletion of esxN did not alter abundance of the downstream espG 5 transcript in either the WT or ∆pstA1 mutant 301 background ( Fig. 5A ), suggesting that the ∆esxN deletion is not polar. To verify that EsxN is not 302 produced or secreted by the ∆esxN and ∆pstA1∆esxN mutants, we performed Western blots.
303
While secreted EsxN was not detected in either the WT or ∆esxN strains, a protein or proteins 304 that reacted with our anti-EsxN anti-serum was still detected in the secreted fraction of the 305 ∆pstA1∆esxN mutant, though at a decreased level compared to the ∆pstA1 parental control 306 ( Fig. 5B ). These data suggest that while EsxN itself is hyper-secreted by the ∆pstA1 mutant, our 307 anti-EsxN anti-serum also detects one or more of the four EsxN paralogs encoded outside the 308 esx-5 locus that each exhibit >92.5% amino acid sequence identity with EsxN (37). Similar 309 cross-reactivity of anti-EsxN anti-serum was previously described (17). Our data further suggest 310 that secretion of one or more of these EsxN paralogs is also increased in the ∆pstA1 mutant.
311
We performed additional Western blots to verify that the ∆esxN deletion did not alter 312 production of ESX-5 core components. Because co-dependent secretion of substrates has been 313 observed for the ESX-1 secretion system (38-40), we also examined if deletion of esxN altered 314 PPE41 secretion. Deletion of esxN in WT M. tuberculosis did not change production of the ESX-315 5 proteins EspG 5 or EccB 5 , but did cause an increase in PPE41 secretion (Fig. 5B) . It is 316 possible that in the absence of EsxN, other ESX-5 substrates like PPE41 are more efficiently 317 secreted. Both EspG 5 and EccB 5 were also produced at similar levels in the ∆pstA1∆esxN 318 double mutant compared to the ∆pstA1 mutant (Fig. 5B ). The ∆pstA1∆esxN mutant hyper-319 secreted PPE41, like the ∆pstA1 mutant (Fig. 5B) . The ModD and GroEL2 controls demonstrate 320 equivalent loading of culture filtrate and cell lysate fractions, respectively ( Fig. 5B ). Overall, our 321 data suggest that EsxN is not required for production or stability of the ESX-5 components 322 EccB 5 or EspG 5 and that EsxN and PPE41 are secreted independently.
323
To investigate if deletion of esxN could reverse attenuation of ΔpstA1 mutant, like the 324 ∆BS mutation, we infected Irgm1 -/-, NOS2 -/and C57BL/6 mice via the aerosol route with ~100 325 CFU the ∆pstA1∆esxN mutant. In contrast to the ∆pstA1∆BS mutant that replicated 326 progressively in the lungs of Irgm1 -/mice ( Fig. 4A) , replication of the ∆pstA1∆esxN mutant was 327 well controlled in Irgm1 -/mice ( Fig. 5C ). There was no significant difference in CFU recovered 328 from the lungs of ∆pstA1-and ∆pstA1∆esxNinfected Irgm1 -/mice at any time point ( Fig. 5C ).
329
The ∆pstA1∆esxN mutant remained attenuated in NOS2 -/mice and during the chronic phase of 330 infection in C57BL/6 mice ( Fig. 5D and 5E ), similar to the ∆pstA1∆BS mutant. Bacterial burdens 331 in the lungs were not significantly different in either NOS2 -/mice or C57BL/6 mice infected with 332 the ∆pstA1 mutant or the ∆pstA1∆esxN mutant at any time point (Figs. 5D and 5E). These data 333 suggest that ESX-5 secreted factors other than EsxN contribute to the attenuation of the ∆pstA1 334 mutant in Irgm1 -/mice.
335

DISCUSSION
336
We previously demonstrated that the virulence-associated ESX-5 secretion system is 337 regulated at the transcriptional level by the Pst/SenX3-RegX3 system that stimulates ESX-5 338 secretion in response to P i limitation. By precisely defining the RegX3 binding site in the esx-5 339 locus and creating targeted mutations that specifically disrupt RegX3-mediated regulation of 340 ESX-5 secretion, we show here that regulation of ESX-5 secretion contributes to M. tuberculosis 341 pathogenesis. Our data suggest that the ∆pstA1 mutant is attenuated in Irgm1 -/mice due to 342 hyper-secretion of ESX-5 substrates caused by constitutive activation of RegX3. Our data 343 further suggest that this attenuation is caused by ESX-5 substrates other than EsxN. Our results 344 are consistent with a recent report demonstrating that secretion of the PE_PGRS subfamily of 345 PE proteins, which are likely ESX-5 substrates, is associated with reduced M. tuberculosis 346 virulence in Balb/c mice (20, 41) . We conclude that M. tuberculosis requires precise regulation 347 of ESX-5 secretion during infection for pathogenesis and that ESX-5 substrates other than EsxN 348 play a direct role in the interaction with the host.
349
While our previous work demonstrated that RegX3 directly controls ESX-5 secretion at the 350 transcriptional level and defined a region 5' of the pe19 gene to which RegX3 binds (14), the 351 precise binding site remained unknown. Here we identified a RegX3 binding site sequence at -352 128 to -102 bp relative to the pe19 start codon that consists of three imperfect direct repeats.
353
We further demonstrated that the two 3' direct repeats and 5 bp spacer with the sequence 5'- 
363
Attenuation of the ∆pstA1 mutant specifically in Irgm1 -/mice was almost completely 364 suppressed by deletion of the RegX3 binding site in the esx-5 locus, suggesting that the ∆pstA1 365 mutant is attenuated in these mice due to constitutive ESX-5 secretion. These data also suggest 366 that the ∆pstA1 mutant is sensitive to some host factor other than Irgm1 due to constitutive 367 ESX-5 secretion. Irgm1 and NOS2 act independently to control M. tuberculosis replication (29), 368 so it is possible that constitutive ESX-5 secretion causes increased susceptibility of the ∆pstA1 369 mutant to NOS2-generated nitrosative stress. Alternatively, the ∆pstA1 mutant may fail to 370 induce the generalized leukopenia that is typically observed in infected Irgm1 -/mice (32), 371 leading to improved control of the infection. In Irgm1 -/mice, IFN-γ produced in response to 372 infection causes the lymphatic collapse by stimulating autophagic death of effector T cells (31).
373
Effector T cells may more efficiently recognize and control replication of the ∆pstA1 mutant due 374 to its constitutive secretion of antigenic ESX-5 substrates, so that T cell containment of infection 375 occurs despite reduced T cell abundance. The ∆pstA1 mutant could also interfere with IFN-γ 376 production or signaling due to constitutive ESX-5 secretion. Manipulation of cytokine responses 377 is a plausible explanation considering that ESX-5 has previously been implicated in activating the inflammasome and triggering IL-1β production by infected cells (18, 19) . Finally, the 379 susceptibility of Irgm1 -/mice to infection with intracellular pathogens can be reversed by 380 deletion of a second IFN-γ regulated GTPase Irgm3 (44). In Irgm1 -/cells, mislocalization of 381 effector immunity-related GTPases (IRGs) causes damage to lysosomes, but in cells lacking 382 Irgm1 and Irgm3 the effector IRGs localize to lipid droplets and damage to lysosomes is 383 prevented (45). It is possible that an ESX-5 secreted protein or proteins interferes with the 384 function of either Irgm3 or the effector GTPases to prevent lysosomal damage and enable 385 Irgm1 -/mice to contain replication of the ∆pstA1 mutant. We intend to explore these ideas in our 386 future studies.
387
While constitutive ESX-5 secretion attenuates the ∆pstA1 mutant in Irgm1 -/mice, the 388 ESX-5 substrates responsible for this phenotype remain to be determined. Our data suggest 389 that attenuation is not caused by hyper-secretion of EsxN since the ∆pstA1∆esxN mutant 390 remained attenuated in Irgm1 -/mice. It is possible that one or more of the EsxN paralogs (EsxI,
391
EsxL, EsxO, or EsxV) plays some role in this process. We could still detect secretion of one or 392 more of these proteins from the ∆pstA1∆esxN mutant using our EsxN anti-serum. However, 393 secretion of all EsxN paralogs was undetectable in the ∆pstA1∆BS mutant, suggesting that 394 decreased production of ESX-5 core components reduces secretion of all EsxN paralogs. Our 395 future plans include deleting genes encoding each of the EsxN paralogs individually and in 396 combination to determine whether these proteins collectively influence pathogenesis.
397
Alternatively, PE and/or PPE proteins secreted via ESX-5 may play a role in attenuation of the 398 ∆pstA1 mutant. PE and PPE proteins are strongly immunogenic in mice in a manner dependent 399 on secretion via ESX-5 (21). In addition, some PE and PPE proteins can directly manipulate the 400 functions of host cells (46-48) and, as discussed above, secretion of the PE_PGRS subfamily in 401 particular has previously been associated with reduced virulence (41). We are currently working 402 to define the M. tuberculosis ESX-5 secretome using strains we developed that conditionally 403 express the ESX-5 core component EccD 5 (33) and will explore the potential of these secreted substrates to influence pathogenesis.
405
Although our data indicate that ESX-5 hyper-secretion causes attenuation of the ∆pstA1 in 406 Irgm1 -/mice, aberrant ESX-5 secretion does not contribute substantially to the chronic phase 407 persistence defect of the ∆pstA1 mutant in C57BL/6 mice. We recently described that the 408 ∆pstA1 mutant also exhibits increased release of membrane vesicles (MV) derived from the 409 inner membrane that contain immune-modulatory lipoproteins and lipoglycans (33, 49).
410
Importantly, increased MV release by the ∆pstA1 mutant was independent of ESX-5 secretion 411 system activity (33). We speculate that aberrant MV production could also contribute to 412 attenuation of the ∆pstA1 mutant. The MV-associated lipoprotein LpqH (also known as the 413 19kDa lipoprotein) is a potent TLR2 ligand and signaling through this pathway causes 414 pleiotropic effects on the innate immune system that include promoting the production of the 429 tuberculosis persistence and that other regulators may contribute more substantially to 430 controlling ESX-5 activity during infection. Indeed several transcription factors have been 431 reported to bind within the esx-5 locus and induce transcription of esx-5 genes (34, 57). It is 432 possible that one or more of these regulators plays an important role in controlling ESX-5 433 secretion during infection, which we plan to investigate in our future studies.
435
MATERIALS AND METHODS
436
Bacterial strains and culture conditions. M. tuberculosis Erdman and the derivative ∆pstA1, 437 ∆regX3, and ∆pstA1∆regX3 mutant strains were previously described (24). Construction of 438 strains harboring mutations in the esx-5 RegX3 binding site sequence is described below. Table S2 . Forward primers to 455 amplify the 5' region were designed with a PacI restriction site; reverse primers to amplify the 3'
456
Quantitative PCR primers to amplify internal regions of the genes of interest (pe19, 508 esxN, espG 5 , eccD 5 , udgA, mgtA, and sigA) were designed with similar annealing temperatures 509 (58-60°C) using either Primer Express software (Applied Biosystems) or ProbeFinder Assay 510 Design software (Roche) and are listed in Table S5 . Quantitative RT-PCR reactions were 511 prepared using 2x SYBR Green master mix (Roche), 2.5 µM each primer and 1 µl cDNA and 512 run on a LightCycler 480 (Roche) using the following cycle parameters: 95°C for 10 min; 45 513 cycles of 95°C for 10s, 60°C for 20s, and 72°C for 20s with data collected once per cycle during 514 the extension phase; and one cycle of 95°C for 5s, 65°C for 1m, 97°C with a ramp rate of 0.11 515 °C/s for generation of melting curves. Cycle threshold values (C p , Roche nomenclature) were 516 converted to copy numbers using standard curves for each gene generated using genomic 517 DNA. Gene copy numbers were normalized to sigA.
518
Antisera production. Rabbit polyclonal antisera against EccD 5 , EsxN and PPE41 were 519 previously described (33, 60) . Synthetic antigenic peptides (EccB 5 489-506, 520 EHDTLPMDMTPAELVVPK; EspG 5 283-300, KTVLDTLPYGEWKTHSRV) that were identified 521 with Antigen Profiler and conjugated to keyhole limpet hemocyanin (KLH) were used with 522 TiterMax Gold adjuvant (Sigma) to raise polyclonal antisera against EccB 5 and EspG 5 in rabbits 523 (Pierce Custom Antibodies, Thermo Scientific).
524
Protein preparation for immunoblots. M. tuberculosis cultures were grown at 37˚C with 525 aeration in Sauton's medium or P i -limited (2.5 μM P i ) Sauton's medium for five days as 526 previously described (14) prior to protein isolation. Bacteria were collected by centrifugation
527
(4700 x g, 15 min, 4°C). Culture supernatants were filter sterilized as previously described (14) 528 and Complete EDTA-free protease inhibitor tablets (Roche) were added. Supernatants were 529 concentrated roughly 25-fold by centrifugation (2400 x g, 4°C) using VivaSpin 5 kDa molecular 530 weight cut-off spin columns (Sartorius). Whole cell lysates were prepared by bead beating with 531 0.1 mm zirconia beads (BioSpec Products) in PBS containing Complete EDTA-free protease 532 inhibitors (Roche) and lysates were clarified by centrifugation as previously described (14) 
541
Proteins were detected by Western blotting as previously described (14) using primary anti-sera 542 at the following diutions: rabbit α-EsxN 1:1000; rabbit α-EspG 5 1:1000; rabbit α-EccB 5 1:1000; 543 rabbit α-EccD 5 1:1000; rabbit α-PPE41 1:1000; rabbit α-ModD 1:25000; mouse α-GroEL2 (A) Abundance of the esxN and espG 5 transcripts relative to sigA was determined by quantitative RT-PCR for the indicated strains grown to mid-logarithmic phase in 7H9 complete medium. Results are the means ± standard deviations of 3 independent experiments. Colored # indicates the transcript was not detected in the corresponding mutant. (B) The indicated strains were grown in Sauton's medium without Tween-80. Cell lysates (10 μg) and culture filtrates (5 μg) were separated and analyzed by Western blotting to detect the indicated proteins. Results are from a single experiment and are representative of two independent experiments. (C-E) Aerosol infection of mice. Irgm1 -/-(C), NOS2 -/-(D) or C57BL6/J (E) mice were infected with ~100 CFU of the M. tuberculosis WT, ∆pstA1 or ∆pstA1∆esxN strain. Groups of mice (n=4) were sacrificed at the indicated time points and bacterial CFU were enumerated by plating serial dilutions of lung homogenates. Results are the means ± standard errors of the means and are from single experiment. Data for the ∆pstA1∆esxN mutant in Irgm1 -/mice are representative of two independent experiments. Data for the WT and ∆pstA1 mutant controls are reproduced from Figure 4 .
